LIU GUIKUN has a total of 12 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Australia, Republic of Korea and Singapore. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are ACHIEVE PHARMA UK LTD, MIAO YIWEN and KANGYA OF NINGXIA PHARMACEUTICALS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Republic of Korea | 2 | |
#3 | Singapore | 2 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Mexico | 1 | |
#7 | United States | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Liu Guikun | 11 |
#2 | Liu Guikan | 1 |
Publication | Filing date | Title |
---|---|---|
KR20120137403A | Aildenafil citrate crystal form o, preparation method and use thereof | |
CN1615883A | Compound medicine for treating hepatitis B virus and controlling HBV virus duplication |